Lower Body Negative Pressure to Validate Physiological Monitors

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-55
SponsorMayo Clinic

About this trial

The purpose of this research is to test the accuracy of non-invasive physiological monitors while the body responds to different levels of lower body negative pressure (LBNP).

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Non-obese (BMI<30)

Non-smokers

Free of any systemic diseases including hypertension, diabetes, coronary artery disease, neurologic disease, or any other major medical co-morbidity.

Women will be either surgically sterilized or non-pregnant as determined by a urine pregnancy test (within 48 hours of the study day)

Disqualifiers

Individuals taking GLP-1 medications or compounds known to affect responses of the autonomic nervous system to orthostatic stress (e.g., β-blockers)

Pregnant women

Trial design

Design model

Single group

Treatments tested in this trial

  • Lower Body Negative Pressure with Noninvasive Physiological Monitoring

    Diagnostic test

    Participants will undergo a graded lower body negative pressure protocol using suction levels of 15, 30, 45, 60, 70, 80, 90, and 100 mmHg, each for up to 5 minutes or until presyncopal symptoms or other termination criteria occur. During the procedure, validated reference physiological measurements and investigational noninvasive monitor signals will be collected simultaneously.

Treatment groups

50 Participants
are divided into 1 treatment group
Group A: Healthy Volunteers Undergoing Lower Body Negative PressureExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Arterial Oxygen Saturation During Lower Body Negative Pressure

Arterial oxygen saturation will be measured during lower body negative pressure using noninvasive physiological monitors

Time frame
During the single study visit, from baseline through completion of the lower body negative pressure protocol, up to 40 minutes
2

ECG Waveform During Lower Body Negative Pressure

ECG waveform will be measured during lower body negative pressure using noninvasive physiological monitor

Time frame
During the single study visit, from baseline through completion of the lower body negative pressure protocol, up to 40 minutes
3

Respiratory Rate During Lower Body Negative Pressure

Respiratory rate will be measured during lower body negative pressure using noninvasive physiological monitors

Time frame
During the single study visit, from baseline through completion of the lower body negative pressure protocol, up to 40 minutes
4

Plethysmography Signals During Lower Body Negative Pressure via physiological monitors

Plethysmography signals will be measured during lower body negative pressure from the pulse oximetry. Reported as a non-invasive research metric of central blood volume.

Time frame
During the single study visit, from baseline through completion of the lower body negative pressure protocol, up to 40 minutes

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.